Factors influencing depression endpoints research (FINDER): Study design and population characteristics

European Psychiatry

Volumn 23, Issue 1, 2008, Pages 57-65

  Garcia Cebrian, Ana ^a   Bauer, Michael ^b   Montejo, Angel L ^c   Dantchev, Nicolas ^d   Demyttenaere, Koen ^e   Gandhi, Paul ^a   Grassi, Luigi ^f   Monz, Brigitta U ^g   Perahia, David G S ^a,h   Quail, Deborah ^a   Tylee, Andre ⁱ  

^a ELI LILLY AND COMPANY   (United States)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^c HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^d HÔTEL DIEU   (France)

^e UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^f UNIVERSITY OF FERRARA   (Italy)

^g BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^h Gordon Hospital   (United Kingdom)

ⁱ KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Depression; Europe; Observational study; Quality of life

Indexed keywords

ANALGESIC AGENT; ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMORBIDITY; EUROPEAN QUALITY OF LIFE 5 DIMENSIONS; FEMALE; FOLLOW UP; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PRIORITY JOURNAL; PSYCHOTHERAPY; QUALITY OF LIFE; SHORT FORM 36;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; COMORBIDITY; CROSS-CULTURAL COMPARISON; DEPRESSIVE DISORDER; DISABILITY EVALUATION; EUROPE; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PROSPECTIVE STUDIES; QUALITY OF LIFE; RESEARCH DESIGN; SEVERITY OF ILLNESS INDEX;

EID: 39149128247     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2007.10.002     Document Type: Article

References (48)

1. Anderson I.M., and Haddad P.M. The antidepressant debate should move on. Br J Psychiatry 182 (2003) 551-552
2. Ayuso-Mateos J.L., Vázquez-Barquero J.L., Dowrick C., Lehtinen V., Dalgard O.S., Casey P., et al. Depressive disorders in Europe: prevalence figures from the ODIN study. Br J Psychiatry 179 (2001) 308-316
3. Bagby R.M., Ryder A.G., and Cristi C. Psychosocial and clinical predictors of response to pharmacotherapy for depression. Rev Psychiatr Neurosci 27 (2002) 250-257
4. Bair M.J., Robinson R.L., Eckert G.J., Stang P.E., Croghan T.W., and Kroenke K. Impact of pain on depression treatment response in primary care. Psychosom Med 66 (2004) 17-22
5. Bair M.J., Robinson R.L., Katon W., and Kroenke K. Depression and pain co-morbidity. Arch Intern Med 163 (2003) 2433-2445 A literature review
6. Barsky A.J., Wyshak G., and Klerman G.L. Hypochondriasis. An evaluation of the DSM-III criteria in medical outpatients. Arch Gen Psychiatry 43 (1986) 493-500
7. Bauer M., Monz B.U., Montejo A.L., Quail D., Dantchev N., Demyttenaere K., et al. Prescribing patterns of antidepressants in Europe: results from the Factors Influencing Depression Endpoints Research (FINDER) study. Eur Psychiatry 23 (2008) 57-65
8. Bijl R.V., van Zessen G., Ravelli A., de Rijk C., and Langendoen Y. The Netherlands Mental Health Survey and Incidence Study (NEMESIS): objectives and design. Soc Psychiatry Psychiatr Epidemiol 33 (1998) 581-586
9. Bijur P.E., Silver W., and Gallagher J. Reliability of the visual analogue scale for measurement of acute pain. Acad Emerg Med 8 (2001) 1153-1157
10. Bosworth H.B., Hays J.C., George L.K., and Steffens D.C. Psychosocial and clinical predictors of unipolar depression outcome in older adults. Int J Geriatr Psychiatry 17 (2002) 238-246
11. Brooks R., and with the EuroQoL Group. EuroQol: the current state of play. Health Policy 37 (1996) 53-72
12. Chakravarty E.F., and Fries J.F. Science as experiment; science as observation. Nat Clin Pract Rheumatol 2 (2006) 286-287
13. Collins S.L., Moore A., and McQuay H.J. The visual analogue pain intensity scale: what is moderate pain in millimetres?. Pain 72 (1997) 95-97
14. Crawford J.R., Henry J.D., Crombie C., and Taylor E.P. Normative data for the HADS from a large non-clinical sample. Br J Clin Psychol 40 (2001) 429-434
15. Dolan P. Modeling variations for EuroQol health states. Med Care 35 (1997) 1095-1108
16. ESEMeD/MHEDEA 2000 Investigators. Prevalence of mental disorders in Europe: results from the European Study of Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand 109 Suppl. 420 (2004) 28-37
17. Fleck M., Simon G., Herrman H., Bushnell D., Martin M., Patrick D., and On behalf of the LIDO Group. Major depression and its correlated in primary care settings in six countries. Br J Psychiatry 186 (2005) 41-47
18. Garcia-Cebrian A., Gandhi P., Demyttenaere K., and Peveler R. The association of depression and pain physical symptoms - a review of the European literature. Eur Psychiatry 21 (2006) 379-399
19. Geddes J., Butler R., Hatcher S., Cipriani A., Price J., Carney S., et al. Depressive disorders. Clin Evid 12 (2004) 1391-1436
20. Gibson J.L., Martin D.K., and Singer P.A. Evidence, economics and ethics: resource allocation in health services organizations. Health Care Q 8 (2005) 50-59
21. Goldney R.D., Fisher L.J., Wilson D.H., and Cheok F. Major depression and its associated morbidity and quality of life in a random, representative community sample. Aust N Z J Psychiatry 34 (2000) 1022-1029
22. Greenberg P.E., and Birnbaum H.G. The economic burden of depression in the US: societal and patient perspectives. Expert Opin Pharmacother 6 (2005) 369-376
23. Haro J.M., Kontodimas S., Negrin M.A., Ratcliffe M., Suarez D., and Windmeijer F. Methodological aspects in the assessment and treatment effects in observational health outcome studies. Appl Health Econ Health Policy 5 (2006) 11-25
24. Hartz A., and Marsh J.L. Methodologic issues in observational studies. Clin Orthop Relat Res 413 (2003) 33-42
25. Hays R.D., Wells K.B., Sherbourne C.D., Rogers W., and Spritzer K. Functioning and well-being outcomes of patients with depression compared with chronic general medical illnesses. Arch Gen Psychiatry 52 (1995) 11-19
26. Herrmann C. International experiences with the Hospital Anxiety and Depression Scale - A review of validation data and clinical results. J Psychosom Res 42 (1997) 17-41
27. Herrman H., Patrick D.L., Diehr P., Martin M.L., Fleck M., Simon G.E., et al. Longitudinal investigation of depression outcomes in primary care in six countries: the LIDO study. Functional status, health service use and treatment of people with depressive symptoms. Psychol Med 32 (2002) 889-902
28. International Network for Agencies for Health Technology Assessment (INAHTA). Available from:. http://inahta.org/inahta_web/index.asp [accessed 25.11.06]
29. Keller M.B. Past, present and future directions for defining optimal treatment outcome in depression. Remission and beyond. J Am Med Assoc 289 (2003) 3152-3160
30. Kelly A.M. The minimum clinically significant difference in visual analogue scale pain score does not differ with severity of pain. Emerg Med J 18 (2001) 205-207
31. Kennedy S.H. A review of antidepressant treatments today. Eur Neuropsychopharmacol 16 Suppl. 5 (2006) S619-S623
32. Lepine J.P., and Briley M. The epidemiology of pain in depression. Hum Psychopharmacol Clin Exp 19 (2004) S3-S7
33. Lepine J.P., Gastpart M., Mendlewicz J., Tylee A., and On behalf of the DEPRES steering committee. Depression in the community: the first pan-European study DEPRES (Depression Research in European Society). Int Clin Psychopharmacol 12 (1997) 19-29
34. Murray C.J., and Lopez A.D. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet 349 (1997) 1498-1504
35. Mykletun A., Stordal E., and Dahl A.A. Hospital anxiety and depression (HAD) scale: factor structure, item analysis and internal consistency in a large population. Br J Psychiatry 179 (2001) 540-544
36. Olsson I., Mykletun A., and Dahl A.A. The hospital anxiety and depression rating scale: a cross-sectional study of psychometrics and case finding abilities in general practice. BMC Psychiatry 5 (2005) 46
37. Paykel E.S., Brugha T., and Fryers T. Size and burden of depressive disorders in Europe. Eur Neuropsychopharmacol 15 (2005) 411-423
38. Peveler R., George C., Kinmonth A.L., Campbell M., and Thompson C. Effect of antidepressant drug counselling and information leaflets on adherence to drug treatment in primary care: randomised controlled trial. BMJ 319 (1999) 612-615
39. Simon G.E. Long-term prognosis of depression in primary care. Bull World Health Organ 78 (2000) 439-445
40. Szadoczky E., Rozsa S., Zambori J., and Furedo J. Predictors for 2-year outcome of major depressive episode. J Affect Disord 83 (2004) 49-57
41. In: Szende A., and Williams A. (Eds). Measuring self-reported population health: an international perspective based on EQ-5D (2004), Spring Medical Publishing, Hungary
42. Tylee A., Gastpar M., Lepine J.P., and Mendlewicz J. DEPRES II (Depression Research in European Society II): a patient survey of the symptoms, disability and current management of depression in the community. Int Clin Psychopharmacol 14 (1999) 139-151
43. Tylee A., and Ghandi P. The importance of somatic symptoms in depression in primary care. Prim Care Companion J Clin Psychiatry 7 (2005) 167-176
44. Ware J.E., Gandek B., Kosinski M., Aaronson N.K., Apolone G., Brazier J., et al. The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithims in 10 countries: results from the IQOLA project. J Clin Epidemiol 51 (1998) 1167-1170
45. Ware J.E., Kosinski M., and Dewey J.E. How to score version 2 of the SF-36 health survey (2000), Quality Metric Incorporated, Lincoln, RI
46. Wells K.B., Stewart A., Hays R.D., Burnam M.A., Rogers W., Daniels M., et al. The functioning and well-being of depressed patients. Results from the medical outcomes study. J Am Med Assoc 262 (1989) 914-919
47. Whalley D., and McKenna S.P. Measuring quality of life in patients with depression or anxiety. Pharmacoeconomics 8 (1995) 305-315
48. Zigmond A.S., and Snaith R.P. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 67 (1983) 361-370